Kent Snyder

Director/Board Member presso SENOMYX INC.

70 anni

Health Technology

Consumer Services

Consumer Non-Durables

Profilo

Kent Snyder is currently a Director at Senomyx, Inc. and a Director at VentiRx Pharmaceuticals, Inc. He was previously an Independent Director at Santarus, Inc. from 2011 to 2014.
He also served as a Director at BioAtla, Inc. and as the President-Global Commercial Operations at Agouron Pharmaceuticals LLC from 1991 to 2001.
Mr. Snyder holds an MBA from Rockhurst University and an undergraduate degree from the University of Kansas.

Posizioni attive di Kent Snyder

Società	Posizione	Inizio
SENOMYX INC.	Director/Board Member	-
VentiRx Pharmaceuticals, Inc. VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.	Director/Board Member	-

Tutte le posizioni attive di Kent Snyder

Precedenti posizioni note di Kent Snyder

Società	Posizione	Fine
Santarus, Inc. Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.	Director/Board Member	02/01/2014
Agouron Pharmaceuticals LLC Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.	Corporate Officer/Principal	01/10/2001
BIOATLA, INC.	Director/Board Member	-

Vedi nel dettaglio l'esperienza di Kent Snyder

Formazione di Kent Snyder

Rockhurst University	Masters Business Admin
University of Kansas	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kent Snyder

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIOATLA, INC.	Health Technology

Aziende private	4
Agouron Pharmaceuticals LLC Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.	Health Technology
Senomyx, Inc. Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA.	Consumer Non-Durables
Santarus, Inc. Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.	Health Technology
VentiRx Pharmaceuticals, Inc. VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.	Health Technology

Vedi le connessioni aziendali